REMS a cross departmental challenge for drugmakers says PPD

REMS a cross departmental challenge for drugmakers says PPD

5 Minuten

Beschreibung

vor 15 Jahren
The US FDA’s risk evaluation mitigation strategy (REMS) can be a
challenge for pharmaceutical companies unfamiliar with the process
according to PPD’s executive director of risk management Frank
Gallo.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15